NBE-Therapeutics is a new Swiss Life-Sciences company focused on the development of novel antibody-based therapeutics. NBE-Therapeutics utilizes a portfolio of in-house developed, externally acquired, and in-licensed novel patent families for the development of novel, best-in-class antibody drug conjugates (ADCs), that can specifically target cancer cells for destruction.
| Building | B2 |
|---|---|
| Industry | Biotech |
| Research Topics | Oncology |
| Employees | 38 |
| Founding year | 2012 |
Home 
About us 
Offer 
News 